ISL1 regulates peroxisome proliferator-activated receptor γ activation and early adipogenesis via bone morphogenetic protein 4-dependent and -independent mechanisms

Molecular and Cellular Biology

Volumn 34, Issue 19, 2014, Pages 3607-3617

  Ma, Xiuquan ^a   Yang, Pengyi ^a,b   Kaplan, Warren H ^a   Lee, Bon Hyang ^a   Wu, Lindsay E ^a,d   Yang, Jean Yee Hwa ^a   Yasunaga, Mayu ^c   Sato, Kenzo ^c   Chisholm, Donald J ^a   James, David E ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c TOTTORI UNIVERSITY   (Japan)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; BMP4 PROTEIN, MOUSE; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN; INSULIN GENE ENHANCER BINDING PROTEIN ISL 1; INSULIN GENE ENHANCER BINDING PROTEIN ISL-1; LIM HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; ISL1 GENE; MICROARRAY ANALYSIS; UPREGULATION; ANIMAL; DNA MICROARRAY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN 4; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION; LIM-HOMEODOMAIN PROTEINS; MICE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PPAR GAMMA; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 84906955091     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00583-14     Document Type: Article

References (58)

1. Rosen ED, Spiegelman BM. 2014. What we talk about when we talk about fat. Cell 156:20-44. http://dx.doi.org/10.1016/j.cell.2013.12.012.
2. Green H, Kehinde O. 1975. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5:19-27.
3. Birsoy K, Chen Z, Friedman J. 2008. Transcriptional regulation of adipogenesis by KLF4. Cell Metab. 7:339-347. http://dx.doi.org/10.1016/j .cmet.2008.02.001.
4. Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. 2005. Krox20 stimulates adipogenesis via C/EBPbeta-dependent and -independent mechanisms. Cell Metab. 1:93-106. http://dx.doi.org/10.1016/j.cmet .2004.12.009.
5. Cao Z, Umek RM, McKnight SL. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5:1538-1552. http://dx.doi.org/10.1101/gad.5.9.1538.
6. Lane MD, Tang QQ, Jiang MS. 1999. Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem. Biophys. Res. Commun. 266:677-683. http://dx.doi.org/10.1006/bbrc.1999 .1885.
7. Yeh WC, Cao Z, Classon M, McKnight SL. 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9:168-181. http://dx.doi.org/10 .1101/gad.9.2.168.
8. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, Spiegelman BM. 2002. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 16:22-26. http://dx.doi.org/10 .1101/gad.948702.
9. Tang QQ, Otto TC, Lane MD. 2003. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. U. S. A. 100:44-49. http://dx.doi.org/10.1073/pnas.0137044100.
10. Chang H, Brown CW, Matzuk MM. 2002. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 23: 787-823. http://dx.doi.org/10.1210/er.2002-0003.
11. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584. http://dx .doi.org/10.1038/nature02006.
12. Heldin CH, Miyazono K, ten Dijke P. 1997. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471. http://dx.doi.org/10.1038/37284.
13. Massague J, Seoane J, Wotton D. 2005. Smad transcription factors. Genes Dev. 19:2783-2810. http://dx.doi.org/10.1101/gad.1350705.
14. Suenaga M, Kurosawa N, Asano H, Kanamori Y, Umemoto T, Yoshida H, Murakami M, Kawachi H, Matsui T, Funaba M. 2013. Bmp4 expressed in preadipocytes is required for the onset of adipocyte differentiation. Cytokine 64:138-145. http://dx.doi.org/10.1016/j.cyto.2013.07.011.
15. Suenaga M, Matsui T, Funaba M. 2010. BMP inhibition with dorsomorphin limits adipogenic potential of preadipocytes. J. Vet. Med. Sci. 72:373- 377. http://dx.doi.org/10.1292/jvms.09-0442.
16. Guo X, Liao K. 2000. Analysis of gene expression profile during 3T3-L1 preadipocyte differentiation. Gene 251:45-53. http://dx.doi.org/10.1016 /S0378-1119(00)00192-X.
17. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM. 2001. Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J. Biol. Chem. 276:34167-34174. http://dx.doi.org/10.1074/jbc.M104421200.
18. Burton GR, Guan Y, Nagarajan R, McGehee RE. 2002. Microarray analysis of gene expression during early adipocyte differentiation. Gene 293:21-31. http://dx.doi.org/10.1016/S0378-1119(02)00726-6.
19. Jessen BA, Stevens GJ. 2002. Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts. Gene 299:95-100. http://dx.doi.org/10 .1016/S0378-1119(02)01017-X.
20. Burton GR, Nagarajan R, Peterson CA, McGehee RE, Jr. 2004. Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis. Gene 329:167-185. http://dx.doi.org/10.1016/j.gene.2003.12 .012.
21. Shewan AM, van Dam EM, Martin S, Luen TB, Hong W, Bryant NJ, James DE. 2003. GLUT4 recycles via a trans-Golgi network (TGN) subdomain enriched in syntaxins 6 and 16 but not TGN38: involvement of an acidic targeting motif. Mol. Biol. Cell 14:973-986. http://dx.doi.org/10 .1091/mbc.E02-06-0315.
22. Yasunaga M, Masui E, Oji A, Soma A, Osaki M, Nakanishi T, Sato K. 2013. Identification of the control region of pancreatic expression of Bmp4 in vitro and in vivo. PLoS One 8:e61821. http://dx.doi.org/10.1371 /journal.pone.0061821.
23. Morita S, Kojima T, Kitamura T. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063-1066. http://dx.doi.org/10.1038/sj.gt.3301206.
24. Tan SX, Ng Y, Meoli CC, Kumar A, Khoo PS, Fazakerley DJ, Junutula JR, Vali S, James DE, Stockli J. 2012. Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes. J. Biol. Chem. 287:6128-6138. http://dx.doi.org/10.1074/jbc.M111.318238.
25. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
26. Carvalho BS, Irizarry RA. 2010. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26:2363-2367. http://dx.doi.org /10.1093/bioinformatics/btq431.
27. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249- 264. http://dx.doi.org/10.1093/biostatistics/4.2.249.
28. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3. http://dx.doi.org/10.1292/jvms.09-0442.
29. Asyali MH, Alci M. 2005. Reliability analysis of microarray data using fuzzy c-means and normal mixture modeling based classification methods. Bioinformatics 21:644-649. http://dx.doi.org/10.1093/bioinformatics/bti036.
30. Tai YC, Speed TP. 2006. A multivariate empirical Bayes statistic for replicated microarray time course data. Ann. Stat. 34:2387-2412. http: //dx.doi.org/10.1214/009053606000000759.
31. Li H, Heilbronn LK, Hu D, Poynten AM, Blackburn MA, Shirkhedkar DP, Kaplan WH, Kriketos AD, Ye J, Chisholm DJ. 2008. Islet-1: a potentially important role for an islet cell gene in visceral fat. Obesity (Silver Spring) 16:356-362. http://dx.doi.org/10.1038/oby.2007.76.
32. Tang QQ, Otto TC, Lane MD. 2003. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc. Natl. Acad. Sci. U. S. A. 100:850-855. http://dx.doi.org/10.1073/pnas.0337434100.
33. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. 2003. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 107:1626-1631. http://dx.doi.org/10 .1161/01.CIR.0000057974.74060.68.
34. Hino J, Miyazawa T, Miyazato M, Kangawa K. 2012. Bone morphogenetic protein-3b (BMP-3b) is expressed in adipocytes and inhibits adipogenesis as a unique complex. Int. J. Obes. (Lond.) 36:725-734. http://dx .doi.org/10.1038/ijo.2011.124.
35. Piccolo S, Sasai Y, Lu B, De Robertis EM. 1996. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86:589-598. http://dx.doi.org/10.1016/S0092-8674(00)80132-4.
36. Hammarstedt A, Hedjazifar S, Jenndahl L, Gogg S, Grunberg J, Gustafson B, Klimcakova E, Stich V, Langin D, Laakso M, Smith U. 2013. WISP2 regulates preadipocyte commitment and PPARgamma activation by BMP4. Proc. Natl. Acad. Sci. U. S. A. 110:2563-2568. http://dx .doi.org/10.1073/pnas.1211255110.
37. Gupta RK, Arany Z, Seale P, Mepani RJ, Ye L, Conroe HM, Roby YA, Kulaga H, Reed RR, Spiegelman BM. 2010. Transcriptional control of preadipocyte determination by Zfp423. Nature 464:619-623. http://dx .doi.org/10.1038/nature08816.
38. Kim JB, Wright HM, Wright M, Spiegelman BM. 1998. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc. Natl. Acad. Sci. U. S. A. 95:4333-4337. http://dx.doi.org/10.1073 /pnas.95.8.4333.
39. Farmer SR. 2005. Regulation of PPARgamma activity during adipogenesis. Int. J. Obes. (Lond.) 29(Suppl 1):S13-S16. http://dx.doi.org/10.1038 /sj.ijo.0802907.
40. Farmer SR. 2006. Transcriptional control of adipocyte formation. Cell Metab. 4:263-273. http://dx.doi.org/10.1016/j.cmet.2006.07.001.
41. Tzameli I, Fang H, Ollero M, Shi H, Hamm JK, Kievit P, Hollenberg AN, Flier JS. 2004. Regulated production of a peroxisome proliferatoractivated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J. Biol. Chem. 279:36093-36102. http: //dx.doi.org/10.1074/jbc.M405346200.
42. Hata K, Nishimura R, Ikeda F, Yamashita K, Matsubara T, Nokubi T, Yoneda T. 2003. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol. Biol. Cell 14:545-555. http://dx.doi.org/10.1091/mbc.E02-06-0356.
43. Tang QQ, Lane MD. 2012. Adipogenesis: from stem cell to adipocyte. Annu. Rev. Biochem. 81:715-736. http://dx.doi.org/10.1146/annurev -biochem-052110-115718.
44. Tang QQ, Otto TC, Lane MD. 2004. Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc. Natl. Acad. Sci. U. S. A. 101:9607-9611. http://dx.doi.org/10.1073/pnas.0403100101.
45. Huang HY, Song TJ, Li X, Hu LL, He Q, Liu M, Lane MD, Tang QQ. 2009. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc. Natl. Acad. Sci. U. S. A. 106:12670-12675. http://dx.doi.org/10.1073/pnas.0906266106.
46. Jin W, Takagi T, Kanesashi SN, Kurahashi T, Nomura T, Harada J, Ishii S. 2006. Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins. Dev. Cell 10:461-471. http://dx.doi.org/10.1016/j .devcel.2006.02.016.
47. Seale P, Kajimura S, Yang W, Chin S, Rohas LM, Uldry M, Tavernier G, Langin D, Spiegelman BM. 2007. Transcriptional control of brown fat determination by PRDM16. Cell Metab. 6:38-54. http://dx.doi.org/10 .1016/j.cmet.2007.06.001.
48. Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, Spiegelman BM. 2009. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 460:1154-1158. http://dx.doi.org/10.1038/nature08262.
49. Qian SW, Tang Y, Li X, Liu Y, Zhang YY, Huang HY, Xue RD, Yu HY, Guo L, Gao HD, Liu Y, Sun X, Li YM, Jia WP, Tang QQ. 2013. BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 110:E798- E807. http://dx.doi.org/10.1073/pnas.1215236110.
50. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y, Roberts DJ, Huang PL, Domian IJ, Chien KR. 2009. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460:113- 117. http://dx.doi.org/10.1038/nature08191.
51. Kritzik MR, Krahl T, Good A, Krakowski M, St-Onge L, Gruss P, Wright C, Sarvetnick N. 2000. Transcription factor expression during pancreatic islet regeneration. Mol. Cell. Endocrinol. 164:99-107. http: //dx.doi.org/10.1016/S0303-7207(00)00234-3.
52. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, Bu L, Sasaki M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, Chien KR. 2006. Multipotent embryonic isl1_ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127: 1151-1165. http://dx.doi.org/10.1016/j.cell.2006.10.029.
53. Son JW, Kim MK, Park YM, Baek KH, Yoo SJ, Song KH, Son HS, Yoon KH, Lee WC, Cha BY, Son HY, Kwon HS. 2011. Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals. Endocr. J. 58:39-46. http://dx.doi.org /10.1507/endocrj.K10E-248.
54. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VKK, O'Rahilly S. 1997. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J. Clin. Invest. 100:3149-3153. http://dx.doi.org/10.1172/JCI119870.
55. Carey DG, Cowin GJ, Galloway GJ, Jones NP, Richards JC, Biswas N, Doddrell DM. 2002. Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected]. Obes. Res. 10:1008- 1015. http://dx.doi.org/10.1038/oby.2002.137.
56. Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA. 2002. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 87:2784-2791. http://dx.doi.org/10.1210/jcem.87.6 .8567.
57. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. 1996. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638. http://dx.doi.org/10.2337 /diab.45.5.633.
58. Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ. 2013. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr. Rev. 34:463-500. http://dx.doi .org/10.1210/er.2012-1041.